Genetic variation in cfh predicts phenytoin-induced maculopapular exanthema in european-descent patients

HIGHLIGHTS

• who: Eunice J. Zhang and colleagues from the predictors of hypersensitivity to anticonvulsant therapy and opens up a new for understanding the biology underlying cutaneous adverse reactionsThis finding can advance genetic testing in the clinic as it expands the array of genetic tests available to aid clinicians in reducing overall rates of discontinuation due to adverse events and improving patient safety. From Molecular and Cellular Therapeutics (M.M., N.D., G.L.C.) and FutureNeuro Research Centre (G.L.C.), Royal College of Surgeons in Ireland, Dublin have published the research work: Genetic variation in CFH predicts . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.